We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,399,560 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
TIDMGSK
RNS Number : 7598M
GlaxoSmithKline PLC
17 October 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Dr M M Slaoui === ======================== =============================================== b) Position/status Chairman, Global Vaccines === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Performance Share Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $42.39 1414.687 --------- ---------- $42.39 1569.750 --------- ---------- $42.39 1797.585 --------- ---------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 4,782.022 $42.39 === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr N Hirons === ======================== =============================================== b) Position/status SVP, Global Ethics & Compliance === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Performance Share Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $42.39 85.247 --------- ---------- === ======================== =============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr B McNamara === ======================== =============================================== b) Position/status CEO, GSK Consumer Healthcare === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Performance Share Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $42.39 42.422 --------- ---------- $42.39 71.440 --------- ---------- $42.39 211.994 --------- ---------- $42.39 357.084 --------- ---------- $42.39 551.108 --------- ---------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 1234.048 $42.39 === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr D E Troy === ======================== =============================================== b) Position/status SVP & General Counsel === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ===============================================
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Performance Share Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $42.39 876.858 --------- ---------- $42.39 972.968 --------- ---------- $42.39 1128.822 --------- ---------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 2978.648 $42.39 === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Dr K Slaoui === ======================== =============================================== b) Position/status PCA of Dr M M Slaoui (Chairman, Global Vaccines) === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Performance Share Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $42.39 22.991 --------- ---------- $42.39 24.324 --------- ---------- $42.39 25.675 --------- ---------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 72.99 $42.39 === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDDLFFQBFZFBD
(END) Dow Jones Newswires
October 18, 2016 02:00 ET (06:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions